연구성과로 돌아가기

2023 연구성과별 연구자 정보 (346 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Carbon-based organic radical spin filters Cho, Daeheum Cho, DH 1 교신저자 Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea D-9235-2018 Cho, Daeheum 0000-0002-0322-4291 Cho, Daeheum daeheumc@knu.ac.kr;
Carbon-based organic radical spin filters Cho, Daeheum Cho, DH 1 교신저자 Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea D-9235-2018 Cho, Daeheum 0000-0002-0322-4291 Cho, Daeheum daeheumc@knu.ac.kr;
Carbon-supported vanadium nitride catalyst, prepared from urea-loaded MIL-100(V) in the absence of external ammonia flow, having good performance in oxidative desulfurization Ahmed, Imteaz Ahmed, I 1 교신저자 Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea imteaz2004@gmail.com;sung@knu.ac.kr;
Carbon-supported vanadium nitride catalyst, prepared from urea-loaded MIL-100(V) in the absence of external ammonia flow, having good performance in oxidative desulfurization Ahmed, Imteaz Ahmed, I 1 교신저자 Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea imteaz2004@gmail.com;sung@knu.ac.kr;
Carbon-supported vanadium nitride catalyst, prepared from urea-loaded MIL-100(V) in the absence of external ammonia flow, having good performance in oxidative desulfurization Kim, Chul-Ung Kim, CU 2 Korea Res Inst Chem Technol KRICT, Chem & Proc Technol Div, POB 107,141 Gajeong Ro, Daejeon 34114, South Korea imteaz2004@gmail.com;sung@knu.ac.kr;
Carbon-supported vanadium nitride catalyst, prepared from urea-loaded MIL-100(V) in the absence of external ammonia flow, having good performance in oxidative desulfurization Jhung, Sung Hwa Jhung, SH 3 교신저자 Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea AAO-6683-2021 Jhung, Sung 0000-0002-6941-1583 Jhung, Sung Hwa imteaz2004@gmail.com;sung@knu.ac.kr;
Carbon-supported vanadium nitride catalyst, prepared from urea-loaded MIL-100(V) in the absence of external ammonia flow, having good performance in oxidative desulfurization Jhung, Sung Hwa Jhung, SH 3 교신저자 Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea AAO-6683-2021 Jhung, Sung 0000-0002-6941-1583 Jhung, Sung Hwa imteaz2004@gmail.com;sung@knu.ac.kr;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Pivot, Xavier Pivot, X 1 교신저자 Inst Cancerol Strasbourg Europe, Strasbourg, France x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Cortes, Javier Cortés, J 2 Quironsalud Grp, Int Breast Canc Ctr, Pangaea Oncol, Barcelona, Spain ADX-3837-2022 CORTES CASTAN, JAVIER x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Cortes, Javier Cortés, J 2 Med Scientia Innovat Res, Dept Sci, Valencia, Spain ADX-3837-2022 CORTES CASTAN, JAVIER x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Cortes, Javier Cortés, J 2 Univ Europea Madrid, Fac Biomed & Hlth Sci, Dept Med, Madrid, Spain ADX-3837-2022 CORTES CASTAN, JAVIER x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Lueftner, Diana Lüftner, D 3 Immanuel Hosp Mark Schweiz, Campus Rudersdorf, Rudersdorf Bei Berlin, Germany x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Lueftner, Diana Lüftner, D 3 Med Univ Brandenburg Theodor Fontane, Campus Rudersdorf, Rudersdorf Bei Berlin, Germany x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Lyman, Gary H. Lyman, GH 4 Fred Hutchinson Canc Res Ctr, Seattle, WA USA K-5227-2019 Lyman, Gary x.pivot@icans.eu;
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial Curigliano, Giuseppe Curigliano, G 5 Univ Milan, European Inst Oncol, IRCCS, Milan, Italy D-3371-2018 Curigliano, Giuseppe 0000-0003-1781-2518 Curigliano, Giuseppe x.pivot@icans.eu;
페이지 이동: